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Abstract
Background: We previously demonstrated that 25-hydroxyvitamin D3, the precursor of 1a,25-dihydroxyvitamin D3,i s
abundant around periodontal soft tissues. Here we investigate whether 25-hydroxyvitamin D3 is converted to 1a,25-
dihydroxyvitamin D3 in periodontal soft tissue cells and explore the possibility of an autocrine/paracrine function of 1a,25-
dihydroxyvitamin D3 in periodontal soft tissue cells.
Methodology/Principal Findings: We established primary cultures of human gingival fibroblasts and human periodontal
ligament cells from 5 individual donors. We demonstrated that 1a-hydroxylase was expressed in human gingival fibroblasts
and periodontal ligament cells, as was cubilin. After incubation with the 1a-hydroxylase substrate 25-hydroxyvitamin D3,
human gingival fibroblasts and periodontal ligament cells generated detectable 1a,25-dihydroxyvitamin D3 that resulted in
an up-regulation of CYP24A1 and RANKL mRNA. A specific knockdown of 1a-hydroxylase in human gingival fibroblasts and
periodontal ligament cells using siRNA resulted in a significant reduction in both 1a,25-dihydroxyvitamin D3 production and
mRNA expression of CYP24A1 and RANKL. The classical renal regulators of 1a-hydroxylase (parathyroid hormone, calcium
and 1a,25-dihydroxyvitamin D3) and Porphyromonas gingivalis lipopolysaccharide did not influence 1a-hydroxylase
expression significantly, however, interleukin-1b and sodium butyrate strongly induced 1a-hydroxylase expression in
human gingival fibroblasts and periodontal ligament cells.
Conclusions/Significance: In this study, the expression, activity and functionality of 1a-hydroxylase were detected in human
gingival fibroblasts and periodontal ligament cells, raising the possibility that vitamin D acts in an autocrine/paracrine
manner in these cells.
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Introduction
Vitamin D3 is a major component in the regulation of calcium
and phosphorus metabolism. The function of vitamin D3, via the
active hormonal metabolite 1a,25-dihydroxyvitamin D3
(1,25OH2D3), is to regulate the absorption of these essential
minerals in the intestine, and their mobilization in bone tissues [1].
1,25OH2D3 also plays an important role in the regulation of T cell
function and immunological reaction [2]. The biological function
of 1,25OH2D3 is orchestrated by vitamin D receptor (VDR). After
binding with VDR, 1,25OH2D3 acts on the vitamin D responsive
element (VDRE) located upstream of its target genes (eg.
CYP24A1, RANKL, et al.) and up-regulates their expression
which results in the corresponding biological effects [3,4,5,6,7].
1,25OH2D3 is formed from vitamin D3 in a two-step
hydroxylation: 25-hydroxyvitamin D3 (25OHD3) hydroxylated in
the liver is transported to the kidney by vitamin D binding protein
(DBP) and is metabolized to 1,25OH2D3 by the renal cytochrome
P450 enzyme 25OHD3-1a-hydroxylase CYP27B1 [8].
Besides the kidney [9,10,11], there are extra-renal sites of
1,25OH2D3 synthesis, including the skin [12], prostate [13],
activated monocytes/macrophages [14], bone [15,16] and sebo-
cytes [17]. Furthermore, local production of 1,25OH2D3 in extra-
renal tissues has been postulated to regulate parameters of cell
growth and differentiation in an autocrine or paracrine fashion
[15,18].
Periodontal tissues consist of two hard tissues, bone and
cementum, and two soft tissues, gingiva and periodontal ligament.
Although bone-derived cells, osteoblast-like cells and osteoblasts
can synthesize 1,25OH2D3 [15,16], it is unknown whether this
also occurs in periodontal soft tissues. Human gingival fibroblasts
(hGF) and human periodontal ligament cells (hPDLC) are two
kinds of periodontal fibroblasts and are important components of
gingiva and periodontal ligament, respectively. Whether
1,25OH2D3 synthesis occurs in these cells warrants further
investigation.
Our previous studies [19,20] demonstrated that levels of plasma
25OHD3 of patients with aggressive periodontitis were signifi-
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in gingival crevicular fluids were 300 times higher than plasma
levels in these patients. It is not known why the precursor of
1,25OH2D3 is abundant around periodontal soft tissues. Recently,
McMahon et al. reported that 1,25OH2D3 could enhance the
antibacterial defense of human gingival epithelial cells [21]. Thus,
if 25OHD3 is converted to 1,25OH2D3 by the cells of periodontal
soft tissues, this conversion could enhance the innate immune
defense in the oral cavity. Here we hypothesized that hGF and
hPDLC have 1a-hydroxylase activity and can convert 25OHD3 to
1,25OH2D3. The objective of this study was to test the above
hypothesis.
Results
1a-hydroxylase mRNA was detected in all the cells of the five
donors (Fig. 1 and 2). The 1a-hydroxylase protein was detected
with an antibody that detects 1a-hydroxylase expression in human
osteoblasts, indicating that the 1a-hydroxylase in hGF and
hPDLC could be the same CYP27B1 enzyme as that found in
osteoblasts [15,16].
After confirming the expression of 1a-hydroxylase in hGF and
hPDLC, the function of 1a-hydroxylase was investigated. While
1000 nM 25OHD3 did not have a significant cytotoxic effect on
any of the cells within 48 h. hGF and hPDLC generated
1,25OH2D3 in response to 25OHD3 and the amount of
1,25OH2D3 increased with incubation time (Fig. 3A, B). The fact
that extra- and intracellular 1,25OH2D3 was generated in the
presence of 25OHD3 provides the most convincing evidence of the
existence of 1a-hydroxylase in hGF and hPDLC. Although the
total amounts of 1,25OH2D3 synthesized by hGF and hPDLC
were not significantly different, more 1,25OH2D3 was released by
hPDLC 12 h after adding 25OHD3. At all other time points, there
was no significant difference in the levels of intracellular and
extracellular 1,25OH2D3 between the two cell types. Moreover,
CYP27B1 mRNA expression peaked at 1 h and no difference was
detected between 0 h and any other time point (Fig. 3C).
CYP24A1 mRNA expression increased over time and was
significant higher at 24 h and 48 h than at 0 h (Fig. 3D).
In addition, exposure to 25OHD3 also resulted in an up-
regulation of the 1,25OH2D3 responsive genes CYP24A1 and
RANKL in hGF and hPDLC (Fig. 4A, B), which is further
evidence of 1a-hydroxylase activity in hGF and hPDLC.
Based on this direct evidence for 1a-hydroxylase activity in hGF
and hPDLC, we examined the effect of 1a-hydroxylase knock-
down. The efficiency of RNA interference against CYP27B1 was
over 70% (Fig. 5). The generation of 1,25OH2D3 increased with
increasing 25OHD3 concentrations but dropped significantly
when CYP27B1 was knocked down using specific siRNA
(Fig. 6A, B).
Although 1,25OH2D3 is the major ligand of VDR, 25OHD3
could bind VDR with lower affinity and have a biological effect
[22]. To address this issue, we knocked down CYP27B1 and found
that the expression of CYP24A1 and RANKL decreased
significantly (Fig. 7A, B), which strongly suggests that the effect
of 25OHD3 in hGF and hPDLC occurs after its conversion to
1,25OH2D3. This is additional evidence for the activity of 1a-
hydroxylase in hGF and hPDLC.
After a comprehensive confirmation of 1a-hydroxylase activity
in hGF and hPDLC, the regulation of 1a-hydroxylase in hGF and
hPDLC was investigated. Parathyroid hormone (PTH), calcium,
1,25OH2D3 and Porphyromonas gingivalis lipopolysaccharide (Pg-
LPS) did not significantly influence CYP27B1 mRNA expression
in hGF and hPDLC (Fig. 8A). In contrast, interleukin-1b (IL-1b)
and sodium butyrate strongly induced CYP27B1 expression
independently of 1,25OH2D3 (Fig. 8B). In addition, no significant
differences in the regulation of CYP27B1 was observed between
hGF and hPDLC.
Despite the detection of the two kinds of DBP receptor
expression, megalin mRNA expression was not detected. Both
mRNA and protein expression of cubilin were detected in hGF
and hPDLC (Fig. 9, 10).
Discussion
Interestingly, the 1,25OH2D3 produced by hGF and hPDLC
can influence vitamin D-responsive gene expression (Fig. 4, 7), an
observation that provides a solid indication of an autocrine/
paracrine action of vitamin D in periodontal fibroblasts. Because
metabolism of 25OHD3 and 1,25OH2D3 by CYP24A1 is very
important in the autocrine/paracrine action of vitamin D, we
investigated the time course of CYP27B1 and CYP24A1 mRNA
expression. CYP27B1 was only up-regulated at 1 h, while
CYP24A1 mRNA expression increased over time (Fig. 3C, D).
The results indicated that as more 1,25OH2D3 was synthesized,
CYP24A1 was more robustly expressed, which resulted in more
conversion of 1,25OH2D3 to 1,24,25OH3D3 and 25OHD3 to
24,25OH2D3, in turn resulting in less substrate for 1,25OH2D3
synthesis. Thus, hGF and hPDLC could regulate their own
1,25OH2D3 generation; this provided further evidence for
autocrine/paracrine action of vitamin D.
Vitamin D binding protein (DBP) is the plasma carrier of
vitamin D in humans [23]. Nykjaer et al. [24,25] confirmed that
vitamin D enters cells by receptor-mediated endocytosis and via
the endocytic receptors megalin and cubilin. In the present study,
cubilin mRNA and protein were detected in hGF and hPDLC
(Fig. 9, 10), however, megalin was not detected despite the use of
two pairs of primers. Atkins et al. [16] reported that osteosarcoma
cell lines and primary osteoblast-like cells express abundant cubilin
mRNA but only osteosarcoma cell lines express megalin mRNA.
The cells used in our study were primary cells and their expression
of DBP receptors was similar to the DBP receptor expression in
primary osteoblast-like cells. Due to the presence of DBP
receptors, plentiful 25OHD3 around periodontal fibroblasts [20]
could be used as a substrate for 1,25OH2D3 synthesis. In addition,
extracellular 1,25OH2D3 (Fig. 3A, 6A), generated by hGF and
hPDLC, could enter the surrounding cells through cellular uptake
associated with DBP, which suggests the possibility of paracrine
action of vitamin D.
In the present study, CYP24A1 and RANKL mRNA expression
were chosen to test the downstream biological effects of 25OHD3.
It is striking that the biological effects caused by the locally
produced 1,25OH2D3 after 1000 nM 25OHD3 treatment were
much stronger than those achieved with exogenous 10 nM
Figure 1. mRNA expression of CYP27B1 in hGF and hPDLC.
mRNA expression of CYP27B1 was detected by RT-PCR in hGF and
hPDLC from all five donors (each lane represents one donor). GAPDH
was used as an internal control.
doi:10.1371/journal.pone.0039878.g001
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of osteoblasts [15]. After 1000 nM 25OHD3 treatment,
1,25OH2D3 concentration in the supernatants of hGF and
hPDLC were 120 pM–360 pM and 120 pM–600 pM, respective-
ly, much lower than 10 nM, but the biological effects were much
stronger. One reason might be that after 25OHD3 treatment,
1,25OH2D3 is found not only in the supernatant but also in the
cell lysates, allowing intracellular 1,25OH2D3 to bind VDR and
influence the function of these cells directly. On the other hand,
exogenous 1,25OH2D3 should enter the cells before eliciting
a response. Thus, the direct availability at the site of action might
be of great importance.
IL-1b in gingival crevicular fluids of patients with periodontitis
reduced significantly after initial periodontal therapy, indicating
that IL-1b is associated with periodontitis [20]. Porphyromonas
gingivalis is an important pathogen of periodontitis and butyrate is
its metabolite [26]. In our previous studies [27,28], we demon-
strated that the butyrate concentrations in gingival crevicular fluids
Figure 2. Protein expression of CYP27B1 in hGF and hPDLC. Protein expression of CYP27B1 was detected by Western blot in hGF and hPDLC
from all five donors (donors are numbered 1–5). b-actin was used as an internal control.
doi:10.1371/journal.pone.0039878.g002
Figure 3. Activity of 1a-hydroxylase in hGF and hPDLC. hGF and hPDLC from donors 2, 3 and 5 were incubated with 1000 nM 25OHD3 for the
times indicated and the production of 1,25OH2D3 was determined in (A) supernatants and (B) cell lysates. After prolonged incubation, production of
1,25OH2D3 increased. hPDLC released more 1,25OH2D3 than hGF 12 h after incubation with 25OHD3. The data is presented as the mean6SE. ** hGF
generated significantly less 1,25OH2D3 than hPDLC at the same time point (p,0.05). The time course of CYP27B1 (C) and CYP24A1 (D) mRNA
expression is also presented. CYP27B1 mRNA expression peaked at 1 h and no difference was detected between 0 h and any other time point.
CYP24A1 mRNA expression was significantly higher at 24 h and 48 h than 0 h. * CYP27B1 or CYP24A1 mRNA expression at the time point was
significantly different from that at 0 h in hGF (p,0.05). # CYP27B1 or CYP24A1 mRNA expression at the time point was significantly different from
that at 0 h in hPDLC (p,0.05).
doi:10.1371/journal.pone.0039878.g003
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of healthy controls and butyrate levels in gingival crevicular fluids
were significantly correlated with periodontal inflammation. To
investigate the regulation of 1a-hydroxylase in hGF and hPDLC,
IL-1b, Pg-LPS and sodium butyrate were chosen for the current
study. However, although stimuli with periodontal characteristics
were used here to simulate a periodontitis condition, this does not
properly model a chronic disease situation in vivo and can only
help to investigate the regulation of CYP27B1 in hGF and
hPDLC. We found the NF-kB activator IL-1b to be a potent up-
regulator of CYP27B1 mRNA in hGF and hPDLC (Fig. 8), which
is in line with the observation in osteoblasts [15]. We also found
that sodium butyrate could significantly up-regulate the expression
of CYP27B1 while Pg-LPS could not, an observation which
requires further study. Classical renal regulators of 1a-hydroxylase
are parathyroid hormone, calcium and 1,25OH2D3 [10,29].
Renal 1,25OH2D3 synthesis is primarily stimulated by low serum
calcium, and consequently by parathyroid hormone that up-
regulates CYP27B1 expression while 1,25OH2D3 itself down-
regulates CYP27B1 by negative feedback [30]. In contrast to this,
we found that 1a-hydroxylase expression in hGF and hPDLC was
less sensitive to a regulation by these agents (Fig. 8). In addition,
1,25OH2D3 did not significantly change the up-regulation of
CYP27B1 by IL-1b and sodium butyrate. A possible explanation
might be that the induction of 1a-hydroxylase in hGF and hPDLC
involves NF-kB pathways that are different from those involved in
renal, cAMP-mediated protein kinase A signaling [31,32] and
negative vitamin D response element [33,34]. This concept is
similar to that of Hewison [35].
In the present study, each donor supplied both hGF and
hPDLC and the CYP27B1 activity of hGF and hPDLC was
compared. We demonstrated that hPDLC released more
1,25OH2D3 than hGF 12 h after adding 25OHD3. In the study
of van D M et al. [15], osteoblasts incubated with 1000 nM
25OHD3 also generated 1,25OH2D3 and the concentration of
1,25OH2D3 in the supernatant was about 400–800 pM. In the
present study, 1,25OH2D3 concentrations in the supernatants of
hGF and hPDLC were 120 pM–360 pM and 120 pM–600 pM,
respectively. Thus, osteoblasts might release more 1,25OH2D3
than hGF and hPDLC. hGF and hPDLC are two different types of
fibroblasts of periodontal soft tissues. It has previously been
demonstrated that hPDLC has a higher degree of similarity with
osteoblasts than hGF [36,37,38]. This might be the reason for the
higher release of 1,25OH2D3 by hPDLC than by hGF.
In recent years, increasing attention has been paid to the
relationship between vitamin D and periodontitis. Dietrich et al.
[39] reported that serum 25OHD3 concentrations are significantly
and inversely associated with attachment loss in people aged over
50 years, however, there is no significant association between
serum 25OHD3 concentrations and attachment loss in patients
younger than 50 years. Dietrich et al. [40] also reported that
subjects with high serum 25OHD3 concentrations were less likely
to have bleeding on probing compared to subjects with low serum
Figure 4. Effect of 25OHD3 incubation on gene expression in hGF and hPDLC. hGF and hPDLC from all five donors were treated with
1000 nM 25OHD3, 10 nM 1,25OH2D3 or vehicle for 48 h and mRNA expression of (A) CYP24A1 and (B) RANKL was examined by real-time PCR. The up-
regulation observed after 1000 nM 25OHD3 treatment was significantly stronger than that observed after 10 nM 1,25OH2D3 treatment. The data are
presented as the mean6SE. * denotes difference from vehicle (p,0.05). ** denotes difference from vehicle and 1,25OH2D3 (p,0.05).
doi:10.1371/journal.pone.0039878.g004
Figure 5. Efficiency of RNA interference against CYP27B1. All
cells were transfected with either a siRNA oligonucleotide for CYP27B1
or a non-silencing control. Using real-time PCR as a measure, the
efficiency of RNA interference against CYP27B1 was over 70% in hGF
and hPDLC from all 5 donors. Donors are numbered 1–5. The data are
presented as the mean6SD. * denotes difference from vehicle (p,0.05).
doi:10.1371/journal.pone.0039878.g005
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were not distinguishable from patients with either aggressive
periodontitis or chronic periodontitis, and local 25OHD3 levels in
gingival crevicular fluids were not detected in these studies. Thus,
we designed our previous studies and found that patients with
aggressive periodontitis had higher plasma 25OHD3 concentra-
tions than healthy controls and that after periodontal therapy the
higher plasma 25OHD3 concentrations were significantly reduced,
indicating that 25OHD3 might be involved in periodontal
inflammation [19,20]. In addition, local 25OHD3 levels in gingival
crevicular fluids were 300 times higher than plasma levels in
patients with aggressive periodontitis [20]. Because 1,25OH2D3
may enhance the antibacterial defense of human gingival epithelial
cells [21], the confirmation of 1a-hydroxylase activity in hGF and
hPDLC implies that local 25OHD3 in gingival crevicular fluids
might be metabolized to 1,25OH2D3 by hGF and hPDLC and be
involved in the innate immune defense in the oral cavity. From this
perspective, 1a-hydroxylase activity in hGF and hPDLC may
benefit periodontal health. Recently, it was reported that calcium
and vitamin D supplementation have a positive effect on
periodontal health [41,42]. However, topical application of
vitamin D has not been reported. Since hGF and hPDLC have
the ability to synthesize 1,25OH2D3, a topical application of
25OHD3 might fulfill the function of 1,25OH2D3. Thus, our data
Figure 6. Effect of CYP27B1 silencing on 1,25OH2D3 generation. hGF and hPDLC from donors 2, 3 and 5 were treated with 25OHD3 at various
concentrations indicated in the figure for 48 h after transfection with the siRNA oligonucleotide for CYP27B1 or a non-silencing control and
1,25OH2D3 production was measured in (A) supernatants and (B) cell lysates. When CYP27B1 was not silenced, production of 1,25OH2D3 increased
with increasing concentration of 25OHD3. When CYP27B1 was silenced, the generation of 1,25OH2D3 decreased significantly compared with when
CYP27B1 was not silenced. The data are presented as the mean6SE. * hGF generated significantly less 1,25OH2D3 with the same amount of 25OHD3
when CYP27B1 was knocked down (p,0.05). # hPDLC generated significantly less 1,25OH2D3 (with the same amount of added 25OHD3) when
CYP27B1 was knocked down (p,0.05).
doi:10.1371/journal.pone.0039878.g006
Figure 7. Effect of CYP27B1 silencing on gene up-regulation by 25OHD3. hGF and hPDLC from all five donors were treated with 1000 nM
25OHD3 for 48 h after transfection with the siRNA oligonucleotide for CYP27B1 or a non-silencing control and mRNA expression of (A) CYP24A1 and
(B) RANKL was determined by real-time PCR. Compared with the transfection with a non-silencing control, transfection with the siRNA
oligonucleotide for CYP27B1 resulted in a significantly weaker up-regulation of CYP24A1 and RANKL in both hGF and hPDLC. The data are presented
as the mean6SE. * denotes difference from control (p,0.05).
doi:10.1371/journal.pone.0039878.g007
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periodontal therapy.
Because no established cell lines of hGF or hPDLC are
available, the cells used in the present study were all obtained from
primary culture. Although all data were obtained from cell from at
least 3 donors, the existence of individual differences among the
cells from primary culture was the limitation of this study.
In conclusion, the results in the current study have identified for
the first time hGF and hPDLC as new sites of extrarenal synthesis
of 1,25OH2D3. Similar to other extrarenal 1a-hydroxylases,




The study protocol was approved by the institutional review
board of Peking University School and Hospital of Stomatology
(PKUSSIRB-2011007) and written informed consent was ob-
tained from each participant in accordance with the Declaration of
Helsinki.
Cell culture
Primary culture of hGF and hPDLC was carried out according
to previously described methods [7,26,36,43]. Briefly, hPDLC
were prepared from extracted third molars of 5 young healthy
volunteers and hGF were obtained from gingiva of the same 5
donors. The periodontal ligament tissues attached to the middle
third of the roots were gently curetted by a surgical scalpel, minced
and inoculated into 24-well plates. Gingiva from different donors
was also minced and inoculated into 24-well plates. Tissue
explants were maintained in Dulbecco’s Modified Eagle’s Medium
(DMEM; Gibco, Grand Island, NY, USA) supplemented with
10% (v/v) fetal bovine serum (FBS; PAA, Coelbe, Germany),
100 U/ml penicillin G and 100 mg/ml streptomycin. Cultures
were maintained in a humidified atmosphere of 5% (v/v) CO2 at
37uC. After reaching 80% confluence, hGF and hPDLC were
digested with 0.25% (w/v) trypsin and 0.02% (w/v) EDTA and
subcultured at a 1:3 ratio.
DMEM without phenol red (Sigma, St. Louis, MO, USA), 10%
dextran-coated charcoal stripped FBS (DCC-FBS; TBD, Tianjin,
China) and cells of passage 4 were used in all of the following
experiments. Experiments were all conducted in triplicate.
Cytotoxicity test of 25OHD3
hGF and hPDLC from three donors were used in the
cytotoxicity test. hGF and hPDLC in their logarithmic phase
were plated into 96-well plates at a density of 3000 cells/well in
DMEM with 10% DCC-FBS. 24 h later, the medium was
replaced by DMEM without DCC-FBS. After another 24 h, the
medium was changed to DMEM with 10% DCC-FBS and
supplemented with 1000 nM 25OHD3 or vehicle, respectively.
The cytotoxicity test was carried out according to the Cell
Figure 8. Preliminary investigation of CYP27B1 regulation in hGF and hPDLC. hGF and hPDLC from donors 2, 3, 4 and 5 were stimulated
with different treatments indicated in the figure for 24 h and CYP27B1 expression was determined by real-time PCR. (A) Pg-LPS, parathyroid hormone,
CaCl2 and 1,25OH2D3 did not significantly influence CYP27B1 mRNA expression. (B) IL-1b and sodium butyrate significantly up-regulated CYP27B1
mRNA expression independently of 1,25OH2D3. Additionally, the characteristics of CYP27B1 regulation in hGF and hPDLC were not significantly
different. The data are presented as the mean6SE. * CYP27B1 mRNA expression was significantly different from that of the vehicle group in hGF
(p,0.05). # CYP27B1 mRNA expression was significantly different from that of the vehicle group in hPDLC (p,0.05). IL-1b: interleukin-1b. Pg-LPS:
Porphyromonas gingivalis lipopolysaccharide. PTH: parathyroid hormone.
doi:10.1371/journal.pone.0039878.g008
Figure 9. mRNA expression of cubilin in hGF and hPDLC. mRNA
expression of cubilin was determined by RT-PCR in hGF and hPDLC
from all five donors (each lane represents one donor). GAPDH was used
as an internal control.
doi:10.1371/journal.pone.0039878.g009
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Briefly, at hours 0, 24 and 48, cells were incubated with CCK-8
for the last 3 h of the culture period after which the optical density
values (OD values) were determined at 490 nm with a microplate
reader (Bio-Rad Model 550, Hercules, CA, USA).
Detection of CYP27B1 expression
Cells from all five donor were seeded into 6-well plates at
a density of 5000/cm
2 in DMEM supplemented with 10% DCC-
FBS. 4 days later, a portion of the cells were harvested using Trizol
agent (Dongsheng Biotech, Guangzhou, China) for RT-PCR.
RNA was extracted using Trizol according to the manufacturer’s
instructions and was reverse transcribed to cDNA using a reverse
transcription kit (Bio-Rad, Hercules, CA, USA). PCR reactions
were performed using the Taq PCR MasterMix (Tiangen Biotech,
Beijing, China) in a Hybaid PCR Thermal Cycler (Thermo
Scientific, Boston, Mass, USA). The primers used are listed in
Table 1.
The remaining cells were harvested using lysis buffer [20 mM
Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
(v/v) Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-
glycerol phosphate and 2 mM Na3VO4 supplemented with
protease inhibitor cocktail (Roche, Mannheim, Germany)] [43]
for Western blotting. Protein concentration was determined using
the Bicinchoninic Acid Protein Assay Kit (Applygen, Beijing,
China). 20 mg of total protein from each sample was loaded onto
a gel comprising a 5% (w/v) stacking gel and a 10% (w/v) running
gel. At the end of the electrophoresis, samples were transferred
onto nitrocellulose blotting membranes (Hybond
TM; Amersham
Pharmacia, Little Chalfont, UK). Blots were probed with a sheep
polyclonal antibody to CYP27B1 (diluted 1:200; The Binding Site
Ltd., Birmingham, UK) or a mouse monoclonal antibody to b-
actin (diluted 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA). After washing, blots were incubated with horseradish
peroxidase-linked secondary antibody. The secondary antibody
against sheep (Kirkegaard & Perry Laboratories, Inc., Maryland,
USA) and mouse (Beijing Zhongshan Golden Bridge Biotechnol-
ogy, Beijing, China) were both diluted 1:2500. Antigen-antibody
complexes were detected using the Enhanced Chemiluminescence
reagent (Applygen, Beijing, China).
Measurement of 1,25OH2D3 production
Cells from 3 donors were treated with 1000 nM 25OHD3
(Sigma, St. Louis, MO, USA) for 1 h, 4 h, 12 h, 24 h or 48 h,
after which supernatants were collected and a portion of cells were
scraped in PBS containing 0.2% Triton X-100 and stored at
280uC. Prior to use, cell lysates were sonicated on ice in a sonifier
cell disrupter for 2615 s. 1,25OH2D3 levels in cell supernatants
and cell lysates were detected using a 1,25OH2D3 radioimmuno-
assay kit (DiaSorin, Stillwater, MN) according to the manufac-
turer’s instructions. The cross-reactivity with 25OHD3 was less
than 0.01%.
In addition, a portion of the cells were harvested using Trizol
reagent for the detection of the time course of CYP27B1 and
CYP24A1 mRNA expression using real-time PCR. Real-time
PCR reactions were performed using SYBRH Premix Ex Taq
TM
II (TaKaRa Biotechnology, Dalian, China) in an ABI 7500 real-
time Thermocycler (Applied Biosystems, Foster city, CA, USA).
Figure 10. Protein expression of cubilin in hGF and hPDLC. hGF and hPDLC from all five donors were used for immunocytochemical staining
of cubilin; expression of cubilin was detected in all the cells examined. Panel A is the negative control for the immunocytochemical staining of cubilin
(4006). Panel B and C contain images of the hGF and hPDLC, respectively, from donor 2 (4006). The primary antibody was replaced with PBS for the
negative control.
doi:10.1371/journal.pone.0039878.g010
Table 1. Primer sequences used for PCR or real-time PCR.
Target genes Forward primer (59R39) Reverse primer (59R39) Products (bp)
CYP27B1 GAAGTGCTAAGACTGTACCCTGT CCTTGAAGTGGCATAGTGACAC 126
RANKL GACATCCCATCTGGTTCCCA CCCAACCCCGATCATGGTA 61
CYP24A1 GACTACCGCAAAGAAGGCTAC CATCACTTCCCCTGGTTTCATTA 105
megalin GCCGGCCAGTGGCCAAGAA ACAGCGCAGCCAATTTCATCC 129
megalin AAATTGAGCACAGCACCTTTGA TCTGCTTTCCTGACTCGAATAATG 151
cubilin TTCTTACGGGGTCTGCTCAAA TGCAAGCCTTGGAATTTTCTCTC 226
GAPDH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC 226
doi:10.1371/journal.pone.0039878.t001
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using the SDS software according to the manufacturer’s instruc-
tions. Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was
used as an internal control. The data are presented as relative
mRNA levels calculated by the equation 2
2DCt (DCt=Ct of target
gene minus Ct of GAPDH) [44].
Detection of CYP24A1 and RANKL mRNA expression
Cells from five donors were incubated with 10 nM 1,25OH2D3
(Sigma, St. Louis, MO, USA), 1000 nM 25OHD3 or vehicle for
48 h before harvesting. Then RNA and cDNA were obtained and
real-time PCR reactions were performed as described previously.
RNA interference of CYP27B1
To confirm the dependence of 25OHD3 conversion into
1,25OH2D3 on CYP27B1, the highly specific technique of RNA
interference was utilized. Cells were seeded at a density of 15000/
cm
2 in 6-well plates. 8 h later, cells were transfected with either
CYP27B1 siRNA (10 nM) or non-silencing control siRNA using
Hiperfect
TM transfection reagent (Qiagen, Duesseldorf, Germany)
according to the manufacturer’s instructions. The target sequence
of CYP27B1 siRNA was 59-CTGGTTTACGGTTTCTTATAA-
39 and the non-silencing control was a non-homologous,
scrambled sequence equivalent.
60 h after transfection, cells were harvested to confirm the effect
of RNAi using real-time PCR. RNA and cDNA were obtained
and real-time PCR was performed as described earlier.
After verifying the effect of RNAi, 1,25OH2D3 production after
RNAi was determined. Cells were first transfected with CYP27B1
siRNA (10 nM) or non-silencing control siRNA and 12 h after
transfection, these cells were treated with 200 nM, 400 nM,
600 nM or 1000 nM 25OHD3 (Sigma, St. Louis, MO, USA) for
another 48 h. Then, the 1,25OH2D3 concentrations in the cell
supernatants and cell lysates were determined as described earlier.
CYP24A1 and RANKL mRNA expression was also examined
after RNAi. Cells were first transfected with CYP27B1 siRNA
(10 nM) or non-silencing control siRNA and 12 h after trans-
fection, these cells were treated with 1000 nM 25OHD3 for
another 48 h. Then, CYP24A1 and RANKL mRNA expression
was determined by real-time PCR.
Regulation of CYP27B1 in hGF and hPDLC
A portion of the cells from four donors were incubated with IL-
1b (PeproTech, London, UK; 1 ng/mL and 10 ng/mL), para-
thyroid hormone (PTH; SinoBio, Shanghai, China; 100 nM and
1 pM), Pg-LPS (Invivogen, San Diego, CA, USA; 1 mg/mL and
10 mg/mL), sodium butyrate (SCRC, Shanghai, China; 4 mM),
CaCl2 (SCRC, Shanghai, China; 4 mM) and 1,25OH2D3 (10 nM)
for 24 h. The other portion of the donor cells were incubated with
IL-1b (1 ng/mL or 10 ng/mL) and 1,25OH2D3 (10 nM) or
sodium butyrate (4 mM) and 1,25OH2D3 (10 nM) for 24 h.
Detection of vitamin D binding protein receptor
expression
The mRNA expression of megalin and cubilin were detected by
RT-PCR as described earlier and the primers used are listed in
Table 1.
Protein expression of cubilin was detected by immunocyto-
chemistry. Cells from five donors were seeded on glass slides at
a density of 20000/cm
2 and 8 h later cells on glass slides were
incubated with primary antibodies against cubilin (diluted 1:50;
Santa Cruz Biotechnology, Santa Cruz, CA, USA). The PV-9000
Polymer Detection System (Zhongshan Golden Bridge Biotech-
nology, Beijing, China) was used for immunocytochemical staining
and a diaminobenzidine (DAB) kit (Zhongshan Golden Bridge
Biotechnology, Beijing, China) was used to develop the colour
followed by haematoxylin staining. The primary antibody was
replaced by PBS for negative controls.
Statistical Methods
The Shapiro-Wilk test was used to determinate the distribution
of the variants. The Wilcoxon test and Friedman test were used to
compare differences between the mRNA expression levels of
CYP24A1 and RANKL in different groups. The effect of RNA
interference and the effect of 25OHD3 exposure on CYP27B1
mRNA expression was analyzed using the paired samples t-test.
Comparison of 1,25OH2D3 generation by hGF and hPDLC,
comparison of 1,25OH2D3 generation with and without knock-
down of CYP27B1 and comparison of CYP27B1 up-regulation in
hGF and hPDLC were all performed using a paired samples t-test.
Statistical analyses were carried out using the SPSS 11.5
software package (SPSS Inc., Chicago, IL, USA). A p value,0.05
was considered statistically significant.
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